(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Cognition Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Monday, April 28th, 2025 | 2023 | John Doyle Chief Financial Officer | 276,667 | 40,000 | 181,210 | 94,067 | 4,150 | 737,263 |
| Monday, April 28th, 2025 | 2024 | Lisa Ricciardi President and Chief Executive Officer | 629,000 | 0 | 445,500 | 304,436 | 18,300 | 1,514,353 |
| Monday, April 28th, 2025 | 2023 | Lisa Ricciardi President and Chief Executive Officer | 586,560 | 0 | 453,623 | 249,288 | 18,300 | 1,660,686 |
| Monday, April 28th, 2025 | 2024 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 486,000 | 0 | 376,200 | 172,072 | 18,300 | 1,146,266 |
| Monday, April 28th, 2025 | 2023 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 446,250 | 0 | 200,141 | 151,725 | 18,300 | 972,124 |
| Monday, April 28th, 2025 | 2024 | John Doyle Chief Financial Officer | 445,000 | 0 | 158,400 | 156,640 | 18,300 | 809,571 |
| Friday, April 26th, 2024 | 2022 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 424,183 | 0 | 0 | 136,000 | 18,300 | 636,267 |
| Friday, April 26th, 2024 | 2023 | John Doyle Chief Financial Officer | 276,667 | 40,000 | 181,210 | 94,067 | 4,150 | 737,263 |
| Friday, April 26th, 2024 | 2023 | Lisa Ricciardi President and Chief Executive Officer | 586,560 | 0 | 453,623 | 249,288 | 18,300 | 1,660,686 |
| Friday, April 26th, 2024 | 2022 | Lisa Ricciardi President and Chief Executive Officer | 550,139 | 0 | 0 | 225,600 | 18,300 | 1,014,539 |
| Friday, April 26th, 2024 | 2023 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 446,250 | 0 | 200,141 | 151,725 | 18,300 | 972,124 |
| Monday, April 24th, 2023 | 2022 | James O’Brien Former Chief Financial Officer | 253,372 | 0 | 0 | 0 | 327,301 | 696,241 |
| Monday, April 24th, 2023 | 2022 | Andrew Einhorn Interim Chief Financial Officer | 319,450 | 0 | 0 | 0 | 0 | 319,450 |
| Monday, April 24th, 2023 | 2021 | James O’Brien Former Chief Financial Officer | 348,769 | 0 | 0 | 155,000 | 11,600 | 1,038,156 |
| Monday, April 24th, 2023 | 2022 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 424,183 | 0 | 0 | 136,000 | 18,300 | 636,267 |
| Monday, April 24th, 2023 | 2021 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 92,788 | 0 | 0 | 0 | 1,319 | 1,684,491 |
| Monday, April 24th, 2023 | 2022 | Lisa Ricciardi President and Chief Executive Officer | 550,139 | 0 | 0 | 225,600 | 18,300 | 1,014,539 |
| Monday, April 24th, 2023 | 2021 | Lisa Ricciardi President and Chief Executive Officer | 409,354 | 0 | 0 | 256,250 | 11,600 | 11,342,127 |
| Monday, April 25th, 2022 | 2020 | Lisa Ricciardi President and Chief Executive Officer | 287,385 | 0 | 0 | 79,893 | 3,415 | 1,272,597 |
| Monday, April 25th, 2022 | 2021 | James O’Brien Chief Financial Officer | 348,769 | 0 | 0 | 155,000 | 11,600 | 1,038,156 |
| Monday, April 25th, 2022 | 2020 | James O’Brien Chief Financial Officer | 340,000 | 0 | 0 | 70,890 | 7,323 | 418,213 |
| Monday, April 25th, 2022 | 2021 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 92,788 | 0 | 0 | 0 | 1,319 | 1,684,491 |
| Monday, April 25th, 2022 | 2020 | Anthony Caggiano, M.D., Ph.D. Chief Medical Officer | 370,000 | 0 | 0 | 0 | 11,400 | 381,400 |
| Monday, April 25th, 2022 | 2021 | Lisa Ricciardi President and Chief Executive Officer | 409,354 | 0 | 0 | 256,250 | 11,600 | 11,342,127 |
